Medtronic plc, MDT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Medtronic plc, MDT has a market cap of 120803.97. Since its IPO date on the 12/31/1981, Medtronic plc, MDT performance year to date is 13.78%. Today Medtronic plc, MDT has gained -1.21%, with a current price of 85.6.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 84.80%. The management of the company have seen the company have a payout ratio of 60.50%. Return of assets are at 3.40%, with return on investment at 5.40%.
In terms of debt levels and profit levels, Medtronic plc, MDT is seeing a long-term debt/equity of 0.58. While Total debt/equity is 0.6. With a profit margin of 12.30%, this is combined with a gross margin of 68.30%, and operating margin of 18.40%. Medtronic plc ability to meet debt levels, with a current ratio of 3.3, while the quick ratio is 2.8.
For the last year Medtronic plc, MDT has seen a EPS growth of 2.90%. A performance for the year of 25.93%. The 52-week high is -4.11%, and the 52-week low is 35.14%. The average volume for Medtronic plc, MDT is 4648695.
With a target price of 90.66, can Medtronic plc, MDT reach this target? Looking at the value indicators of Medtronic plc, MDT. Medtronic plc has a P/E of 34.88 and a forward P/E of 16.76. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.45. Medtronic plc also has a P/S and a P/B of 4.19 and 2.33 respectively. For P/cash, Medtronic plc has a value of 9.56, while it is 59.42 for P/free cash flow.
At the current price of 85.6, Medtronic plc has a dividend yield of 1.98%. We see a return on equity of 6.80%.
Looking more long-term Medtronic plc, is projected to get an EPS growth for the next five years of 7.84%. In the short-term an EPS growth of 11.01% in the next year is forecasted. This is after a EPS growth of 2.90% for this year and for the last five years a -2.60% growth has been seen.